Group 1 - The core viewpoint of the article indicates that Meituan expects a continued improvement in the average loss per order for its food delivery service in Q1 2026 compared to Q4 2025 [2] - Meituan reported a significant reduction in its core local business operating loss, which amounted to 10 billion yuan in Q4 2025, showing a substantial decrease compared to Q3 [2] - The company maintains its leading position in the mid-to-high price order market in terms of Gross Transaction Value (GTV) as of the beginning of Q1 [2]

Core Insights - Meituan's Q4 performance aligns with previous profit warnings, showing no unexpected surprises or additional downward pressure [1] - Morgan Stanley maintains an "Overweight" rating with a target price of HKD 120, emphasizing that market share trends and profit margin recovery remain key variables for stock price direction [1] Financial Overview - Total revenue for Q4 reached RMB 92.1 billion, a 4% year-on-year increase, with a 4% quarter-on-quarter decline, closely matching Morgan Stanley's forecast of RMB 92.2 billion and market expectations of RMB 92.3 billion [2] - Gross profit was RMB 24.1 billion, down 28% year-on-year, indicating significant pressure on gross margins [2] - Adjusted net loss was RMB 15.1 billion, with an adjusted net margin of -16.4%, slightly improving from -16.8% in the previous quarter but down 27.5 percentage points from a positive margin of 11.1% a year ago [2] - Operating loss was RMB 16.1 billion, narrowing by 19% quarter-on-quarter, and aligning closely with market expectations [2] Core Local Business - Revenue for the core local business segment was RMB 64.8 billion, a 1% year-on-year decline, slightly missing Morgan Stanley's and market expectations of approximately RMB 65.4 billion [3] - The segment reported an operating loss of approximately RMB 10 billion, transitioning from profit to loss, with an operating margin of -15.5%, down about 35 percentage points year-on-year [3] - The loss was better than Morgan Stanley's forecast of -RMB 11.1 billion and market expectations of -RMB 10.9 billion, aligning with prior profit warnings [3] - Quarter-on-quarter, the operating loss improved from RMB 14.1 billion to RMB 10 billion, with the operating margin improving by approximately 5.4 percentage points [3] New Business Segment - The new business segment generated revenue of RMB 27.3 billion, a 19% year-on-year increase, slightly exceeding Morgan Stanley's and market expectations of RMB 26.9 billion [4] - However, operating losses in this segment expanded significantly from RMB 1.3 billion in the previous quarter to RMB 4.7 billion, with a loss margin of -17.1% [4] - The increase in losses was primarily driven by investments in overseas operations, with the loss slightly worse than Morgan Stanley's forecast of -RMB 4.4 billion [4] Rating and Investment Thesis - Morgan Stanley maintains an "Overweight" rating for Meituan, with a target price of HKD 120, indicating approximately 38% upside potential from the current price of HKD 86.70 [6] - The valuation is based on a DCF model, assuming a 12% weighted average cost of capital and a 3% perpetual growth rate [6] - Key risks include potential recovery in the food delivery market share and profit margin improvements, as well as monetization of merchant ARPU and returns from new business investments [6] - The core local business's margin recovery and market share trends remain critical variables for Meituan's valuation re-evaluation [6]

Core Viewpoint - The CEO of Meituan, Wang Xing, emphasizes that the only reasonable strategy in the AI revolution is to be offensive rather than defensive, viewing AI as a strategic opportunity to improve and transform its core local services business [1][2]. Investment in AI - Since the beginning of 2023, Meituan has made significant investments in capital expenditure and AI talent, likely leading the domestic market in AI investment among companies without cloud computing businesses, having maintained this focus for over three years [3]. - Meituan is continuing to invest in its self-developed foundational model, LongCat, and is collaborating with top third-party models in the industry to accurately understand the real physical world [3]. AI as a Super Entrance - Wang believes that the key to an AI "super entrance" lies in accurately understanding user needs and efficiently executing tasks, which is more complex than just a "chatbot" [3]. - The local lifestyle sector presents complex and diverse consumption scenarios, with a vast amount of merchant information that is not effectively digitized, requiring in-depth management of fulfillment and delivery, a capability that general AI lacks [3]. AI Assistant "Xiaotuan" - Meituan's AI assistant, "Xiaotuan," can quickly extract valuable information from online reviews and infer personalized answers to meet user needs based on a wealth of physical world information [2][3]. - An example provided illustrates the complexity of user needs, where AI must integrate map information, points of interest, and real-time restaurant supply data to fulfill a common request for dining options [2]. Future Development - The company plans to continuously optimize model capabilities and deepen the integration of "Xiaotuan" within the Meituan app, aiming to make it the preferred platform for addressing local lifestyle needs [4]. - Meituan intends to enhance AI search capabilities and execution abilities, striving to upgrade the app into a leading AI-driven application and the future AI entrance for local lifestyle demands [4].

Market Overview - On March 26, US stock indices opened lower but saw a short-term rebound, with the Dow Jones Industrial Average rising by 0.1%, while the Nasdaq fell by 0.64% and the S&P 500 declined by 0.38% [8][10]. Technology Sector Performance - Major tech stocks experienced more declines than gains, with Nvidia and Google dropping over 1%, Tesla down 0.7%, and Facebook hitting its lowest level since May 2025, down 2.8% due to a lawsuit related to social media harm to teenagers [10][12]. - The Philadelphia Semiconductor Index fell by 2.45%, led by declines in the storage chip sector, with SanDisk down over 6%, Micron Technology, Western Digital, and Seagate Technology down over 4% [10][12]. - Other notable declines included ASML and TSMC down over 3%, and Intel and AMD down over 2% [10][12]. Chinese Stocks - The Nasdaq Golden Dragon China Index fell by 1.47%, with several popular Chinese stocks declining, including Xiaoma Zhixing down over 14%, and XPeng, Sohu down over 4%, while Alibaba, Bilibili, and Baidu Group fell over 2% [11][12]. Commodity Market - Spot gold fell over 1.3%, currently priced at $4453 per ounce, while silver's decline narrowed to 3%, priced at $69 per ounce [12]. - International oil prices saw both WTI and Brent crude oil rise over 3%, with WTI at $93.5 per barrel and Brent at $101 per barrel [12]. Cryptocurrency Market - Major cryptocurrencies continued to decline, with Bitcoin down over 2.67%, priced at $69,542 per ounce, and a total of nearly 90,000 liquidations in the market over the past 24 hours [12][13].

Core Insights - The company reported a total revenue of 574 million yuan for the year 2025, with significant contributions from its commercialized products [2] - The first commercial product, Nairike, achieved sales of 435 million yuan, marking an 81% year-on-year growth [2] - The second drug, Lisengtuo, was launched in July 2025 and generated sales of 70.58 million yuan by the end of the year [2] - The company’s cash flow improved, ending the period with approximately 2.47 billion yuan in cash [2] Revenue Breakdown - Nairike's sales reached 435 million yuan, benefiting from its inclusion in the national medical insurance drug list [2] - Lisengtuo, as the first domestic Bcl-2 inhibitor, achieved sales of 70.58 million yuan within five months of its launch [2] - Lisengtuo has been approved for reimbursement in 74 projects across 184 cities in 26 provinces [2] Clinical Developments - Nairike received FDA and EMA approval for its global Phase III study for treating Ph+ ALL [3] - Lisengtuo's global Phase III study for treating high-risk MDS patients was also approved by FDA and EMA [3] - The company is advancing multiple Phase III clinical studies, with four receiving regulatory approvals [3] Pipeline and Future Prospects - APG-3288, a new BTK degrader based on PROTAC technology, received clinical application approval from FDA and CDE in January 2026 [4] - APG-2449 is currently in a global Phase III clinical study for non-small cell lung cancer [4] - The company has several other drugs in various stages of clinical trials, covering a range of hematological and solid tumors [4] Capital Market Activity - The company went public on NASDAQ in January 2025, becoming the first biotech company to list in both Hong Kong and the US, raising a net amount of 967 million yuan [4]

Market Overview - The US stock market opened lower with the Nasdaq down 1.08%, the Dow Jones down 0.18%, and the S&P 500 down 0.55% [1] - As of the latest update, the Dow Jones has turned positive with a gain of 0.11%, while the Nasdaq and S&P 500 are down 0.56% and 0.32% respectively [1] - A total of 3,002 stocks rose while 2,089 stocks fell [1] Semiconductor Sector - The semiconductor storage sector experienced a broad decline, with SanDisk down 6.6%, Western Digital, Micron Technology, and Seagate Technology all falling over 4% [1][2] Notable Stock Movements - Marathon Digital Holdings saw a significant increase of over 11% after announcing a $1 billion buyback of convertible senior notes and the sale of 15,133 bitcoins [2] - Major tech stocks showed mixed results, with Meta Platforms down 3.97%, Intel down 3.08%, and Nvidia down 1.93%, while Apple rose by 1.39% [4][5] Chinese Stocks - Most Chinese concept stocks declined, with Xiaoma Zhixing down over 15%, XPeng Motors down 5.41%, and Baidu down 2.79% [7][8] Precious Metals - Both gold and silver prices fell, with gold dropping over 1.23% to $4,449 per ounce and silver decreasing by nearly 3% to $69 per ounce [12][13] Oil Prices - International oil prices continued to rise, with WTI crude oil increasing by 3.96% and Brent crude oil rising over 4%, surpassing $100 per barrel [15][16]

Group 1 - Geely Auto officially launched its commercial presence in Spain with a brand event on March 25, introducing two new energy SUV models: Starray EM-i and Geely E5, which include plug-in hybrid and pure electric technologies [1][2] - The company plans to establish a comprehensive sales and service network across Spain, having already signed cooperation agreements with initial dealers [1] - Spain is identified as a key market for Geely in Europe, with plans to introduce at least nine models over the next three years, including four models in 2026, to meet local consumer demands for design, intelligence, and electrification [2] Group 2 - The acceleration of electric vehicle transformation in Europe is prompting Chinese automakers, including Geely, to expand their international presence, with Spain emerging as a significant market due to its industrial foundation and market potential [2] - Geely aims to leverage its R&D and manufacturing systems in China and Europe to enhance its international competitiveness through localized operations and international collaborations [2]

Core Viewpoint - The Nasdaq China Golden Dragon Index experienced a decline of 1.89% at the beginning of trading, indicating a negative sentiment in the market for Chinese stocks listed in the U.S. [1] Group 1: Stock Performance - Pony.ai (PONY) saw a significant drop of 7.11% [1] - Xpeng Motors (XPEV) decreased by 5.30% [1] - Miniso Group (MNSO) fell by 3.80% [1] - United Microelectronics Corporation (UMC) declined by 3.44% [1] - Zai Lab (ZLAB) dropped by 3.34% [1] - Baidu (BIDU) decreased by 2.78% [1] - NetEase (NTES) fell by 2.65% [1] - Taiwan Semiconductor Manufacturing Company (TSM) declined by 2.47% [1] - Tencent Music (TME) also dropped by 2.47% [1]

Core Insights - Meituan is focusing on stabilizing its core business while rejecting industry "involution" and betting on AI reconstruction in the physical world and the globalization of Keeta [1][2][3] - The company reported a total revenue of 92.1 billion yuan for Q4 2025, a year-on-year increase of 4.1%, with cash and cash equivalents totaling 166.8 billion yuan by the end of 2025 [1][17] - The core local commerce segment generated 64.8 billion yuan in revenue for Q4, while the new business segment, driven by Keeta and retail expansion, reached 27.3 billion yuan, growing by 18.9% year-on-year [1][20] Competition and Regulatory Environment - Meituan's CEO, Wang Xing, firmly opposes "involution" in the industry, emphasizing the need for a healthy and orderly market, particularly in the face of irrational competition driven by subsidies and pricing wars [2][3] - The company is reallocating resources from low-quality orders to defend market share and promote high-quality growth, with expectations of significant improvement in delivery losses in Q1 2026 compared to Q4 2025 [3][32] AI Strategy - AI is a major focus for Meituan, with Wang stating that the company will not rush to become a "token factory" but will actively engage in the AI revolution [3][24] - The company has launched its AI assistant "Xiaoguan" to all users, aiming to create a user-centered local service AI agent that can understand natural language queries [4][15][26] Retail and Global Expansion - Meituan plans to acquire Dingdong's retail business in mainland China for $717 million, which is expected to enhance its supply chain capabilities and service quality in the East China region [5][40][41] - Keeta is accelerating its globalization, with expectations of profitability in Saudi Arabia by the end of 2026, following successful operations in Hong Kong [5][46][47] Financial Performance - In Q4 2025, Meituan's total revenue was 92.1 billion yuan, with a cost of revenue rate increasing by 11.6 percentage points to 33.8% due to higher consumer incentives and rider incentives [17][18] - The core local commerce segment reported an operating loss of 10 billion yuan, significantly narrowing from previous quarters, while the new business segment's operating loss expanded to 4.6 billion yuan due to strategic investments [20][21]

Core Viewpoint - The company's 2025 profit is expected to decline by 13.5% to 2.91 billion RMB, primarily due to lower-than-expected operating profits from wind and solar segments, despite an increase in the final dividend by 3.7% to 0.168 RMB per share, with a dividend payout ratio rising by 10 percentage points to 70% [1] Group 1: Financial Performance - The company recovered approximately 6 billion RMB in subsidy payments, an increase of about 4 billion RMB year-on-year, while capital expenditures decreased by around 10 billion RMB, resulting in a net inflow of free cash flow of 320 million RMB [1] - The company added 1.9 GW of wind and 4.4 GW of solar capacity, with clean energy accounting for 82% of the total installed capacity [1] Group 2: Operational Insights - In 2025, the company plans to add 6.2 GW of wind and solar capacity, although the utilization hours for wind and solar are expected to decline by 1.2% and 7.6% year-on-year, respectively, with grid electricity prices decreasing by 8.2% and 8.3% [2] - The overall power restriction rate is approximately 9%, with wind and solar restriction rates at about 9% and 10.5%, respectively, particularly in the Sanbei region, where restrictions are more pronounced [2] Group 3: Future Outlook - The management estimates annual capital expenditures of around 20 billion RMB during the 14th Five-Year Plan, prioritizing wind projects over solar, aiming to increase the proportion of wind capacity while reducing solar capacity below 30% [3] - The company completed the restructuring of hydropower assets in Q4 2025, with plans to inject major hydropower assets into the platform within three years [3] Group 4: Shareholder Returns - The management emphasizes shareholder returns through enhanced investor communication, quality asset injections, and equity incentives, with plans to consider a 3-5 year dividend guideline and explore the possibility of shifting from fixed ratio dividends to fixed amount dividends [4] - The company maintains a buy rating and a target price of 3.75 HKD [4]